文献速递心外重症与机械循环支持

ECMO插管策略不影响总住院费用

Cannulation Strategy for Extracorporeal Membrane Oxygenation Does Not Influence Total Hospital Cost.
PubMed 文献 · Ann Thorac Surg · 2021-02-11

单中心回顾性研究纳入2017年3月至2018年10月接受ECMO支持的患者(中心VA 29例、外周VA 72例、VV 37例),比较不同初始插管策略的总住院费用与临床资源利用。结果显示总住院费用、住院天数、ICU停留、ECMO支持时长、机械通气时间及血液透析使用在组间均无统计学差异。

要点

  • 中心VA、外周VA与VV ECMO的总住院费用无统计学差异(P = .91)。
  • 不同插管策略的住院天数、ICU停留、ECMO支持时长及透析使用均无显著差异。
  • 按2018年CMS费率估算,理论ECMO报销损失每年可达1,970,698至5,648,219美元。

核心结论

  • ECMO插管策略对资源利用和住院费用影响极小。

研究设计与样本

  • 单中心回顾性队列研究,纳入2017年3月至2018年10月接受ECMO支持的患者,排除转诊医院插管、器官移植受者及临时右心室支持者;按初始插管策略分层为中心VA 29例、外周VA 72例、VV 37例。

主要发现

  • 总住院费用为中心VA $187,848、外周VA $178,069、VV $172,994(P = .91)。
  • 平均住院天数中心VA 25.8天、外周VA 21.5天、VV 26.2天(P = .49);平均ICU停留分别为14.1天、12.8天、7.7天(P = .25)。
  • 平均ECMO支持时长分别为6.5天、6.2天、7.8天(P = .38);平均机械通气时间分别为13.0天、8.2天、10.0天(P = .06)。
  • 血液透析使用率分别为41%、47%、41%(P = .75);30天生存率分别为48%、37%、51%。

关键数值与推荐

  • 按2018年CMS费率,理论ECMO报销损失范围为每年$1,970,698至$5,648,219。

临床怎么用

  • 选择ECMO插管策略时可更多依据临床需要,而非以降低住院费用或资源利用为主要考量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Center for Medicare and Medicaid Services decreased reimbursement rates for peripheral venoarterial (VA) extracorporeal membrane oxygenation (ECMO) and venovenous (VV) ECMO procedures in October 2018. Limited data are available describing hospital costs and clinical resources required to support ECMO patients. METHODS: All patients supported on ECMO at our institution between March 2017 and October 2018 were identified. Exclusion criteria were cannulation at referring hospitals, organ transplant recipients, and temporary right ventricular support. The cohort was stratified by the initial cannulation strategy. Outcomes were total hospital cost and clinical resource utilization. RESULTS: There were 29 patients supported on central VA, 72 on peripheral VA, and 37 on VV ECMO. Survival at 30 days was 48% for central vs 37% for peripheral vs 51% for VV. Hospital costs were $187,848 for central vs $178,069 for peripheral vs $172,994 for VV (P = .91). Mean hospital stay was 25.8 days for central vs 21.5 days for peripheral vs 26.2 days for VV (P = .49). Mean intensive care unit stay was 14.1 days for central vs 12.8 days for peripheral vs 7.7 days for VV (P = .25). Mean length of ECMO support was 6.5 days for central vs 6.2 days for peripheral vs 7.8 days for VV (P = .38). Mean ventilator time was 13.0 days for central vs 8.2 days for peripheral vs 10.0 days for VV (P = .06). Hemodialysis was used in 41% central patients, 47% peripheral, and 41% VV (P = .75). Theoretical ECMO reimbursement losses ranged from $1,970,698 to $5,648,219 annually under 2018 Center for Medicare and Medicaid Services rates. CONCLUSIONS: ECMO cannulation strategy has minimal impact on resource utilization and hospital cost.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Walker KL, Bakir NH, Kotkar KD, et al. Cannulation Strategy for Extracorporeal Membrane Oxygenation Does Not Influence Total Hospital Cost. Ann Thorac Surg. 2021. PMID: 33581159. doi:10.1016/j.athoracsur.2020.12.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。